Mirabegron
13 NDCs across 3 manufacturers|8 Generic,5 Brand
Mirabegron is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 28, 2012, and the first generic was approved Dec 27, 2019. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2.4 billion on Mirabegron across 3.7 million claims for 882,000 beneficiaries.
Mirabegron is available as 13 NDCs from 3 manufacturers (8 generic, 5 brand), with NADAC prices from $9.18 to $14.70 per EA — a 60% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
8G / 5B
Manufacturers
3
competing in market
Price Spread
$9.18 – $14.70
per EA, 12 of 13 NDCs
7d Activity
avg -1.4% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Astellas Pharma US, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
beta3-Adrenergic Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing MIRABEGRON
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MYRBETRIQ ER 50 MG TABLET | $14.6989 per EA | 0.00% |
MYRBETRIQ ER 50 MG TABLET | $14.6989 per EA | 0.00% |
MYRBETRIQ ER 25 MG TABLET | $14.6784 per EA | 0.00% |
MYRBETRIQ ER 25 MG TABLET | $14.6784 per EA | 0.00% |
MIRABEGRON ER 50 MG TABLET | $9.3866 per EA | -2.18% |
MIRABEGRON ER 50 MG TABLET | $9.3866 per EA | -2.18% |
MIRABEGRON ER 50 MG TABLET | $9.3866 per EA | -2.18% |
MIRABEGRON ER 50 MG TABLET | $9.3866 per EA | -2.18% |
MIRABEGRON ER 25 MG TABLET | $9.1767 per EA | -2.37% |
MIRABEGRON ER 25 MG TABLET | $9.1767 per EA | -2.37% |
MIRABEGRON ER 25 MG TABLET | $9.1767 per EA | -2.37% |
MIRABEGRON ER 25 MG TABLET | $9.1767 per EA | -2.37% |
MYRBETRIQ ER 8 MG/ML SUSP | $2.2070 per ML | +0.01% |
Frequently Asked Questions
What is Mirabegron used to treat?
Mirabegron is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
When did Mirabegron become available as a generic?
FDA approved the first generic Mirabegron (ANDA) on Dec 27, 2019. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Mirabegron?
In 2024, Medicare Part D spent $2.4 billion on Mirabegron across 3.7 million claims for 882,000 beneficiaries.
How many Mirabegron products are on the market?
The Mirabegron drug market contains 13 NDCs from 3 manufacturers — 8 generic and 5 brand products.
What is the price range for Mirabegron?
NADAC reference prices for Mirabegron range from $9.1767 to $14.6989 per EA — a 60% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Is generic Mirabegron cheaper than brand?
The average generic NADAC for Mirabegron is $9.2816 per EA, versus $14.6886 for brand-labeled products — generic is about 37% cheaper on average.
Which manufacturers make Mirabegron?
3 manufacturers list Mirabegron in NADAC. Ranked by number of NDCs, the largest are Astellas Pharma US, Inc. (5), Zydus Pharmaceuticals (USA) Inc. (4), Lupin Pharmaceuticals Inc. (4).
How has the price of Mirabegron changed recently?
Over the past 7 days, 1 Mirabegron NDC rose and 8 fell, with a market-wide average change of -1.4%.